Cases 21 - 30 of 342
Federal Trade Commission V. Amgen Inc., et al.
as 1:2023cv03053
Counter Defendant:
Federal Trade Commission
Defendant:
Amgen Inc. and Horizon Therapeutics PLC
Plaintiff:
New York, State of, State of California, State of Illinois and others
Intervenor:
Regeneron Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 0053 Federal Trade Commission Act
In Re: Request from Vienna
as 1:2023mc00258
Petitioner:
Amgen, Inc.
Respondent:
Sandoz, Inc.
Cause Of Action: 28 U.S.C. § 1782 Letter rogatory - appointment
AMGEN INC. et al v. SANDOZ INC. et al
as 1:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. et al v. SANDOZ INC. et al
as 2:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MSP Recovery Claims, Series LLC v. Amgen Inc. et al
as 2:2023cv03130
Plaintiff:
MSP Recovery Claims, Series LLC
Defendant:
Amgen Inc., Onyx Pharmaceuticals, Inc., Onyx Therapeutics, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Racketeering (RICO) Act
OssiFi-Mab LLC v. Amgen Inc.
as 1:2023cv10861
Plaintiff:
OssiFi-Mab LLC
Defendant:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sensipar Cinacalcet Hydrochloride Tablets AntitrusIn re: Sensipar Cinacalcet Hydrochloride Tablets Antitrus
as 23-8020
Plaintiff:
In re: SENSIPAR CINACALCET HYDROCHLORIDE TABLETS ANTITRUST LITIGATION
Respondent:
CESAR CASTILLO LLC, KPH HEALTHCARE SERVICES INC, TEAMSTERS WESTERN REGION & LOCAL 177 HEALTH CARE PLAN and others
Petitioner:
AMGEN INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC and others
Roofers Local No. 149 Pension Fund v. Amgen Inc. et al
as 1:2023cv02138
Plaintiff:
Roofers Local No. 149 Pension Fund
Defendant:
Amgen Inc., Robert A. Bradway and Peter H. Griffith
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United States of America, ex rel Don Hanks v. Amgen Inc.
as 23-28
Plaintiff:
State of California ex rel. Don Hanks, State of Delaware ex rel. Don Hanks, District of Columbia ex rel. Don Hanks and others
Plaintiff / Appellant:
United States of America, ex rel Don Hanks
Defendant / Appellee:
Florida Cancer Specialists, Gulfcoast Oncology Associates, Integrated Community Oncology Network, LLC and others
Defendant:
Amgen Inc., Montgomery Cancer Center, Oncology Specialties, P.C. and others
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
